FDA Clearance Tracker · P210034
Agili-C
Last checked: Nov 20, 2026Latest source record: Mar 29, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Mar 29, 2022
Approved
Time to decision
180 days
Received Sep 30, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P210034
- Device name
- Agili-C
- Applicant
- Smith and Nephew, Inc.
- Applicant location
- Andover, MA
- Received
- Sep 30, 2021
- Decided
- Mar 29, 2022
- Decision
- Approved
- Supplements
- 1 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
Approval for Agili-C. The Agili-C scaffold is indicated for the treatment of an International Cartilage Repair Society (ICRS) grade III or above knee-joint surface lesion(s), with a total treatable area of 1-7cm2, without severe osteoarthritis (Kellgren-Lawrence grade 0-3).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QRU (Implant, resorbable, for articular osteochondral repair).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Smith and Nephew, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K222501 · Decided May 11, 2023 · 266 days after receipt
Device type: Mesh, Surgical, Collagen, Orthopaedics, Reinforcement Of Tendon (OWY) · General & Plastic Surgery
K221740 · Decided Oct 20, 2022 · 127 days after receipt
Device type: Laparoscope, General & Plastic Surgery (GCJ) · GI, Urology & Nephrology
- LENS 4K Camera Control Unit - Wifi, LENS 4K Camera Control Unit - Non-Wifi, LENS 4K Camera Head510(k)
K191177 · Decided Aug 23, 2019 · 113 days after receipt
Device type: Laparoscope, General & Plastic Surgery (GCJ) · GI, Urology & Nephrology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.